Propanc Biopharma PPCB
NASDAQ PPCB
$0.50 -0.01 (-2.36%)
As of: Sep 30, 2026 · 9:38 AM EDT

Propanc Biopharma (PPCB) Other Non-Current Liabilities (2013 - 2025)

Updated

Propanc Biopharma (PPCB) posted Other Non-Current Liabilities of $320,763 for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 143.8% from $131,585 a year earlier and up 91.1% from the prior quarter.

Analysis

Propanc Biopharma (PPCB) Other Non-Current Liabilities (2013 - 2025) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Propanc Biopharma's Other Non-Current Liabilities came in at $403,892, up 201.7% from FY2024.

  • Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
  • In prior fiscal years, Propanc Biopharma's Other Non-Current Liabilities was $133,886 in FY2024 (-68.4%), $423,209 in FY2023 (+179.8%), $151,262 in FY2022 (+179.0%) and $54,220 in FY2021 (-69.4%).
  • Quarterly Other Non-Current Liabilities has run from a low of $10,623 in fiscal Q2 2023 to a high of $423,209 in fiscal Q4 2023 over five years.
  • On a year-over-year basis, Other Non-Current Liabilities has increased in each of the last four quarters, with growth averaging 40.1% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was fiscal Q1 2022, with growth of 882.5%; the weakest was fiscal Q2 2023, with a decline of 95.2%.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior fiscal quarters was $167,878 (Q1 2026), $403,892 (Q4 2025) and $191,770 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Propanc Biopharma 595,565.74 595,565.74 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 320,763.00
Sep 30, 2025 167,878.00
Jun 30, 2025 403,892.00
Mar 31, 2025 191,770.00
Dec 31, 2024 131,585.00
Sep 30, 2024 134,234.00
Jun 30, 2024 133,886.00
Mar 31, 2024 128,432.00
Dec 31, 2023 219,045.00
Sep 30, 2023 119,069.00
Jun 30, 2023 423,209.00
Mar 31, 2023 132,501.00
Dec 31, 2022 10,623.00
Sep 30, 2022 72,958.00
Jun 30, 2022 151,262.00
Mar 31, 2022 56,612.00
Dec 31, 2021 221,977.00
Sep 30, 2021 58,124.00
Jun 30, 2021 54,220.00
Mar 31, 2021 53,189.00
API Access

Propanc Biopharma Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PPCB&period=max&api_key=YOUR_API_KEY